Clinical Trials
- Colorectal Cancer
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Digestive System
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Colorectal Cancer, Sarcoma Cancers, Stomach and Esophagus, Kidney Cancer, Head and Neck Cancers, Liver Cancer, Lung Cancer, Gynecological Cancers, Pancreatic Cancer, Prostate Cancer, Thyroid and Other Endocrine Cancers, Breast Cancer
PROgram to address psychosocial Support, clinical outcomes, and genomic insights for Patients with EaRly onset cancers
- Colorectal Cancer
A Randomized, Open-label Phase 3 Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Digestive System
The OPTIMIZE Trial
- Ages18 years - 80 years
- GenderBoth